Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT00795886 · COMPLETED
Trial details
- NCT number
- NCT00795886
- Sponsor
- University of Utah
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2010-03-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.